Mini Podcast Series Episode 2: Rethinking "Next Generation" Drug Development Strategies

In episode 2 of our mini-podcast series "Through the Biotech Lens: Molecule to Market", our speakers David Cameron,  Senior Director and Global Head of Novel Trial Design and Lucas Glass,  Vice-President of Artificial Intelligence will discuss innovative trial designs that bring together the best of biopharma and technology to bring value to the patient.